Home688089 • SHA
add
Cabio Biotech Wuhan Co Ltd
Previous close
¥25.74
Year range
¥12.11 - ¥30.12
Market cap
4.26B CNY
Avg Volume
4.73M
P/E ratio
29.76
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 155.97M | 33.28% |
Operating expense | 28.36M | 14.84% |
Net income | 45.00M | 85.07% |
Net profit margin | 28.85 | 38.84% |
Earnings per share | — | — |
EBITDA | 61.25M | 78.62% |
Effective tax rate | 14.20% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 207.97M | -10.28% |
Total assets | 1.74B | 7.51% |
Total liabilities | 129.12M | 29.54% |
Total equity | 1.61B | — |
Shares outstanding | 166.65M | — |
Price to book | 2.69 | — |
Return on assets | 6.96% | — |
Return on capital | 7.33% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 45.00M | 85.07% |
Cash from operations | 32.89M | -24.19% |
Cash from investing | -8.13M | 91.11% |
Cash from financing | 29.14M | 30,344.60% |
Net change in cash | 54.82M | 214.44% |
Free cash flow | -39.12M | 20.03% |
About
Founded
1999
Website
Employees
565
